Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets
Bone · 2026
DOI: 10.1016/j.bone.2025.117703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Norichika Mizuki und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Induced Pluripotent Stem Cells, Osteogenesis, Blood Platelets. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Chiba University.
Abstract (Originalsprache)
Bone regeneration (BR) is an ongoing challenge in biomedical research. While recombinant human bone morphogenetic protein-2 (rhBMP-2) is available for clinical use, its side effects remain a concern. Patient-derived platelet-rich plasma has been proposed as an alternative, but its heterogeneity poses a major hurdle to standardization. Here, we evaluated the effectiveness of induced pluripotent stem cell (iPSC)-derived megakaryocytes and platelets (iMPs) and recombinant human bone morphogenetic protein-2 (rhBMP-2) as potential BR therapy in a rat lumbar bone graft model. We implanted artificial bones with iMPs and/or rhBMP-2 and performed computed tomography and histological analysis to assess new bone formation. iMPs and rhBMP-2 showed comparable efficacy in vivo, but rhBMP-2 induced significant inflammation. In vitro, iMPs promoted human bone marrow mesenchymal stem cell (BM-MSC) proliferation and migration, while rhBMP-2 enhanced osteodifferentiation. RNA sequencing revealed cell cycle-related gene upregulation by iMPs. Altogether, these findings suggest iMPs, alone or in combination with rhBMP-2, as a promising BR therapy for enhancing clinical efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: mmukai@chiba-u.jp.
- Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: yshiga1111@yahoo.co.jp.
- Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
- Department of Plastic, Reconstructive, and Aesthetic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Chiba University
- Terumo Corporation
- Terumo Foundation for Life Sciences and Arts
Zitieren
APA
Mizuki, N., Mukai, M., Shiga, Y., Takayama, N., Nakamura, S., Kosaka, K., Chen, S. J., Paul, S. K., Arai, T., Tashiro, S., Sato, M., Fukuyo, M., Rahmutulla, B., Tajiri, I., Inage, K., Suzuki-Narita, M., Eguchi, Y., Orita, S., Kaneda, A., …, & Ohtori, S. (2026). Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets. Bone. https://doi.org/10.1016/j.bone.2025.117703
Vancouver
Mizuki N, Mukai M, Shiga Y, Takayama N, Nakamura S, Kosaka K, et al. Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets. Bone. 2026. doi:10.1016/j.bone.2025.117703
BibTeX
@article{Mizuki2026,
author = {Mizuki, Norichika and Mukai, Michiaki and Shiga, Yasuhiro and Takayama, Naoya and Nakamura, Sou and Kosaka, Kentaro and Chen, Si Jing and Paul, Sudip Kumar and Arai, Takahito and Tashiro, Susumu and Sato, Masashi and Fukuyo, Masaki and Rahmutulla, Bahityar and Tajiri, Ikuko and Inage, Kazuhide and Suzuki-Narita, Miyako and Eguchi, Yawara and Orita, Sumihisa and Kaneda, Atsushi and Eto, Koji and Ohtori, Seiji},
title = {Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2025.117703}
}
EUVIMED